Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Elliott D. Kieff, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Elliott Kieff and Bo Zhao.
Connection Strength

3.263
  1. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci U S A. 2011 Sep 06; 108(36):14902-7.
    View in: PubMed
    Score: 0.486
  2. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines. Proc Natl Acad Sci U S A. 2011 Jan 04; 108(1):337-42.
    View in: PubMed
    Score: 0.468
  3. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells. . 2017 Oct 11; 22(4):561-573.e4.
    View in: PubMed
    Score: 0.187
  4. Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proc Natl Acad Sci U S A. 2016 12 06; 113(49):14121-14126.
    View in: PubMed
    Score: 0.176
  5. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. . 2015 Feb 11; 17(2):205-16.
    View in: PubMed
    Score: 0.155
  6. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Proc Natl Acad Sci U S A. 2015 Jan 13; 112(2):554-9.
    View in: PubMed
    Score: 0.154
  7. The NF-?B genomic landscape in lymphoblastoid B cells. Cell Rep. 2014 Sep 11; 8(5):1595-606.
    View in: PubMed
    Score: 0.151
  8. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc Natl Acad Sci U S A. 2014 Jan 07; 111(1):421-6.
    View in: PubMed
    Score: 0.144
  9. Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proc Natl Acad Sci U S A. 2013 Nov 12; 110(46):18537-42.
    View in: PubMed
    Score: 0.143
  10. Genome-wide siRNA screen for mediators of NF-?B activation. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2467-72.
    View in: PubMed
    Score: 0.126
  11. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. J Virol. 2011 Jul; 85(13):6764-73.
    View in: PubMed
    Score: 0.120
  12. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci U S A. 2011 May 10; 108(19):7808-13.
    View in: PubMed
    Score: 0.120
  13. Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2. Blood. 2007 Jun 15; 109(12):5447-54.
    View in: PubMed
    Score: 0.090
  14. Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol. 2006 Mar; 80(5):2548-65.
    View in: PubMed
    Score: 0.084
  15. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc Natl Acad Sci U S A. 2006 Feb 07; 103(6):1900-5.
    View in: PubMed
    Score: 0.083
  16. Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical. J Virol. 2005 Aug; 79(16):10171-9.
    View in: PubMed
    Score: 0.081
  17. Four EBNA2 domains are important for EBNALP coactivation. J Virol. 2004 Oct; 78(20):11439-42.
    View in: PubMed
    Score: 0.076
  18. Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol. 2018 02; 3(2):1-8.
    View in: PubMed
    Score: 0.048
  19. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease. Proc Natl Acad Sci U S A. 2017 05 02; 114(18):4751-4756.
    View in: PubMed
    Score: 0.045
  20. Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A. 2015 Sep 01; 112(35):11036-41.
    View in: PubMed
    Score: 0.040
  21. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome. Antiviral Res. 2014 Apr; 104:73-83.
    View in: PubMed
    Score: 0.036
  22. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription. Proc Natl Acad Sci U S A. 2014 Jan 07; 111(1):243-8.
    View in: PubMed
    Score: 0.036
  23. Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5. Biochem Biophys Res Commun. 2013 Jan 18; 430(3):1097-102.
    View in: PubMed
    Score: 0.034
  24. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells. PLoS Pathog. 2012; 8(12):e1003084.
    View in: PubMed
    Score: 0.034
  25. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci U S A. 2011 Sep 06; 108(36):14908-13.
    View in: PubMed
    Score: 0.030
  26. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci U S A. 2011 Feb 01; 108(5):1919-24.
    View in: PubMed
    Score: 0.029
  27. Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J Virol. 2009 Dec; 83(23):12368-77.
    View in: PubMed
    Score: 0.027
  28. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol. 2006 Oct; 80(20):10139-50.
    View in: PubMed
    Score: 0.022
  29. Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J. 2005 Oct 19; 24(20):3565-75.
    View in: PubMed
    Score: 0.020
  30. Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation. Proc Natl Acad Sci U S A. 2004 Jan 27; 101(4):1033-8.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.